Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine
medicines (ask patient specifically) May cause ↓ in hemoglobin, hematocrit, and WBC, usually during the
Insulin may increase risk of adverse cardiovascular first 4-8 wk of therapy; then levels stabilize. May cause irreversible ↑ in
AST and ALT or hepatic failure (rare). If ALT increases to >3 times the
reactions. upper limit of normal, recheck ALT promptly. Discontinue rosiglitazone
if ALT remains >3 times normal. May cause ↑ in total cholesterol, LDL,
and HDL and ↓ in free fatty acids